Erratum to “contribution of acute infarcts to cerebral small vessel disease progression”

Annemieke ter Telgte, MSc, ¹* Kim Wiegertjes, MSc,¹* Benno Gesierich, PhD,² José P. Marques, PhD,³ Mathias Huebner, PhD,² Jabke J. de Klerk, MSc,¹ Floris H. B. M. Schreuder, MD,¹ Miguel A. Araque Caballero, PhD,^2,4 Hugo J. Kuijf, PhD,⁵ David G. Norris, PhD,³ Catharina J. M. Klijn, MD,¹ Martin Dichgans, MD,^2,4,6 Anil M. Tuladhar, MD,¹ Marco Duering, MD,^2,6† and Frank‐Erik de Leeuw, MD^1†

From the ¹Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands; ²Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany; ³Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands; ⁴German Center for Neurodegenerative Diseases (DZNE Munich), Munich, Germany; ⁵Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands; and ⁶Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

(Linked https://doi.org/10.1002/ana.25556)

The citation to reference #2 was mistakenly omitted from the first sentence under the section heading entitled “Assessment of MRI Markers on SCD and Lesion Evolution” (page 3, column 2). The complete sentence is listed below. We regret the error.

SVD lesions were assessed blinded to clinical characteristics according to the previously published STandards for Reporting Vascular changes on nEuroimaging (STRIVE).²